Indies Pharma Jamaica Limited (JMSE:INDIES)

Market Cap	4.00B +7.5%
Revenue (ttm)	1.13B -2.8%
Net Income	181.29M -18.0%
EPS	0.14 -18.0%
Shares Out	1.33B
PE Ratio	22.05
Forward PE	n/a
Dividend	0.14 (4.50%)
Ex-Dividend Date	Mar 31, 2025

Volume	35,425
Average Volume	117,688
Open	n/a
Previous Close	3.000
Day's Range	2.760 - 2.990
52-Week Range	2.330 - 3.760
Beta	0.05
RSI	48.64
Earnings Date	Mar 13, 2026

About Indies Pharma Jamaica

Indies Pharma Jamaica Limited engages in the distribution and retail of pharmaceutical and auxiliary products in Jamaica. The company was incorporated in 2003 and is based in Montego Bay, Jamaica. Indies Pharma Jamaica Limited is a subsidiary of Bioprist Holdings Inc.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2003
• Employees: 64
• Stock Exchange: Jamaica Stock Exchange
• Ticker Symbol: INDIES

Financial Performance

In fiscal year 2025, Indies Pharma Jamaica's revenue was 1.13 billion, a decrease of -2.82% compared to the previous year's 1.16 billion. Earnings were 181.29 million, a decrease of -18.04%.